The 26th International Conference on Gastroenterology and Hepatology will convene in Vienna, focusing on artificial intelligence and digital tools in digestive and liver health. It unites global experts to share breakthroughs in endoscopy, microbiome research, GI oncology, and personalized medicine, fostering collaboration and innovation in patient care.

The EASL SLD Summit 2026 in Budapest will spotlight cutting‑edge research and clinical advances in Steatotic Liver Disease, including MASLD, MetALD, and ALD. With interactive sessions, it explores diagnostics, therapies, public health, and patient care. Delegates will engage in multidisciplinary discussions on AI, omics, organoids, nutrition, and therapeutic strategies.

The 17th International Conference on Liver Diseases & Hepatology in Paris will spotlight innovations in liver and gastro care. With a focus on AI and digital health, it unites global experts to share breakthroughs in diagnostics, therapies, and patient care. The congress fosters collaboration, knowledge exchange, and transformative advances in hepatology.

EASL Congress 2026 in Barcelona is Europe’s premier liver health meeting, uniting doctors, scientists, allied health professionals, patients, and industry partners. With 190+ sessions and 2,000+ abstracts, it covers the full spectrum of hepatology. The hybrid format ensures global accessibility, fostering collaboration, innovation, and breakthroughs in liver science and patient care.

The EASL School on Artificial Intelligence in Hepatology in Dresden will train clinicians and researchers in AI literacy, covering machine learning, deep learning, and image processing. Participants will learn to critically evaluate AI studies, develop applications in hepatology, and collaborate across disciplines to advance equitable, explainable, and impactful liver health solutions.

16th World Gastroenterology, IBD, Hepatology Conference & Exhibition (GastroUCG 2026) in Dubai will unite gastroenterologists, hepatologists, IBD specialists, surgeons, and researchers to explore cutting‑edge treatments and innovations. With CME/CPD accreditation, keynote lectures, workshops, and networking, the hybrid congress fosters collaboration and knowledge exchange, advancing clinical practice and research in gastroenterology, hepatology, and inflammatory bowel disease worldwide.

2nd International Summit on Hepatology and Nephrology Research (ISHR-2026) in Paris will unite hepatology and nephrology experts to explore innovations in diagnostics, therapies, and patient care. With CPD credits and abstract publication (DOI/ISBN), the summit covers biomarkers, regenerative therapies, imaging, transplantation, and personalized medicine. It fosters collaboration and knowledge exchange to advance outcomes in liver and kidney health.